BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 2 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 2 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 2 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 2 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 2 days ago Abbott reports positive results from study on its atrial fibrillation therapies 2 days ago Atmus Welcomes Heath Sharp to Board of Directors 2 days ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 2 days ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 4 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 4 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 2 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 2 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 2 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 2 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 2 days ago Abbott reports positive results from study on its atrial fibrillation therapies 2 days ago Atmus Welcomes Heath Sharp to Board of Directors 2 days ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 2 days ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 4 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 4 days ago
ADVERTISEMENT
Market News

Stryker (SYK): Q4 2019 Earnings Snapshot

— Stryker (NYSE: SYK) reported fourth quarter 2019 earnings of $2.49 per share, vs. $2.46 per share expected. — Total sales grew 8.8% to $4.13 billion vs. expected $4.11 billion. Organic sale grew 8% in Q4. Orthopaedics sales increased 6.7% year-over-year to $1.5 billion. — Adjusted EPS is estimated to be in the range of […]

$SYK January 28, 2020 1 min read

— Stryker (NYSE: SYK) reported fourth quarter 2019 earnings of $2.49 per share, vs. $2.46 per share expected.

— Total sales grew 8.8% to $4.13 billion vs. expected $4.11 billion. Organic sale grew 8% in Q4. Orthopaedics sales increased 6.7% year-over-year to $1.5 billion.

— Adjusted EPS is estimated to be in the range of $9.00 to $9.20 for 2020 and in the range of $2.05 and $2.10 for 1Q20.

— 2020 organic net sales growth expected to be 6.5% to 7.5%.

— SYK shares traded flat in the after-hours trading session.

ADVERTISEMENT

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT